Lakewood Amedex Biotherapeutics Inc (LABT)

02:43 AM

Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference - openPR.com

02:43 AM

Sep 08, 2026

Lakewood-Amedex CEO to present new antimicrobia... - Pluang

Sep 08, 2026

Sep 05, 2026

Lakewood-Amedex Biotherapeutics Inc. Common Stock (NASDAQ: LABT) Stock Price, News & Analysis - Kalkine

Sep 05, 2026

Sep 03, 2026

LABT Price Today: Lakewood-Amedex Biotherapeutics Inc. Stock Price, Quote & Chart | MEXC - MEXC

Sep 03, 2026

Sep 01, 2026

Biotech Pre-Market Movers: BIAF, LABT, ALMS, PASW Swing Big - RTTNews

Sep 01, 2026

Sep 01, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Sep 01, 2026

Aug 31, 2026

Trending Stocks Today | SONO Group Soars 81.34% Post-Market - Moomoo

Aug 31, 2026

Aug 31, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Aug 31, 2026

Aug 29, 2026

Lakewood-Amedex Biotherapeutics Company Profile & Introduction - Moomoo

Aug 29, 2026

Aug 26, 2026

Lakewood-Amedex Biotherapeutics Becomes a B2i Digital Featured Company - markets.businessinsider.com

Aug 26, 2026

Aug 16, 2026

Lakewood-Amedex Biotherapeutics (LABT) Stock Trends and Sentiment 2026 $LABT - MarketBeat

Aug 16, 2026

Aug 14, 2026

Lakewood-Amedex Biotherapeutics (LABT) investor WFI Equity discloses 8.8% ownership stake - Stock Titan

Aug 14, 2026

Aug 14, 2026

Lakewood-Amedex raises $7.5M Series C, lists on Nasdaq and clears $1.5M debt - Dealroom

Aug 14, 2026

Aug 14, 2026

Lakewood-Amedex Raises $7.5M and Lists on NASDAQ, Shedding $1.5M Debt - Minichart

Aug 14, 2026

Aug 14, 2026

LABT: Q2 net loss rose sharply on higher R&D and G&A costs; liquidity improved after Series C financing - TradingView

Aug 14, 2026

Aug 14, 2026

Lakewood-Amedex Biotherapeutics Inc. Q2 2026: Revenue $0 Net loss $(3.90M), EPS $(2.75) — 10-Q Summary - TradingView

Aug 14, 2026

Aug 14, 2026

Lakewood-Amedex (NASDAQ: LABT) raises $7.5M, expands cash yet flags going concern - Stock Titan

Aug 14, 2026

Aug 13, 2026

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia

Aug 13, 2026

Aug 10, 2026

Lakewood-Amedex Biotherapeutics announces annual shareholder meeting - Bitget

Aug 10, 2026

Aug 10, 2026

Lakewood-Amedex (NASDAQ: LABT) seeks 100M share authorization and reverse split power - Stock Titan

Aug 10, 2026

Aug 06, 2026

Lindesfarne LLC reports 8.582% LABT stake in Lakewood-Amedex Biotherapeutics (LABT) filing - Stock Titan

Aug 06, 2026

Aug 06, 2026

Lakewood-Amedex Biotherapeutics (LABT) Earnings Date and Reports 2026 $LABT - MarketBeat

Aug 06, 2026

Jul 30, 2026

Lakewood-Amedex Biotherapeutics (LABT) asks investors to approve major share and reverse split powers - Stock Titan

Jul 30, 2026

Jul 24, 2026

Lakewood-Amedex Biotherapeutics Inc. Revenue Breakdown – NASDAQ:LABT - TradingView

Jul 24, 2026

Jul 24, 2026

Lakewood-Amedex Biotherapeutics, Inc. (LABT) stock price, news, quote and history - Yahoo Finance Singapore

Jul 24, 2026

Jul 23, 2026

3 Penny Stocks to Watch Today, 7/23/2026 - TipRanks

Jul 23, 2026

Jul 23, 2026

Lakewood-Amedex Biotherapeutics, Inc. (LABT) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 23, 2026

Jul 23, 2026

Leonard James Deroma Net Worth (2026) - GuruFocus

Jul 23, 2026

Jul 22, 2026

Lakewood-Amedex Biotherapeutics Inc.Common Stock (Nasdaq:LABT) Stock Quote - The Chronicle-Journal

Jul 22, 2026

Jul 22, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex (NASDAQ:LABT) shares jump after Nu-3 news; trading volume more than 200x daily average - TechStock²

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex Biotherapeutics Surges as Fresh Nu-3 Data Draws Attention to Its Antibiotic-Resistance Program - Quiver Quantitative

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex (LABT) Stock Soars 141% on Breakthrough Nu-3 Resistance Data - parameter.io

Jul 22, 2026

Jul 22, 2026

Peter Ceccacci Net Worth (2026) - GuruFocus

Jul 22, 2026

Jul 22, 2026

Kelvin Cooper Net Worth (2026) - GuruFocus

Jul 22, 2026

Jul 22, 2026

Trending Stocks Today | Lakewood-Amedex Biotherapeutics Shoots up 126.34% - Moomoo

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex (LABT) Stock Jumps 141% After Nu-3 Antimicrobial Data Release - CoinCentral

Jul 22, 2026

Jul 22, 2026

LABT Stock Whipsaws As Traders React To Conference Spotlight - StocksToTrade

Jul 22, 2026

Jul 22, 2026

LABT Stock Whipsaws As Traders Eye Virtual Forum Exposure - timothysykes.com

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex reports resistance data for Nu-3 antimicrobial By Investing.com - Investing.com South Africa

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex reports resistance data for Nu-3 antimicrobial - Investing.com

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex announces resistance data for Nu-3 - TipRanks

Jul 22, 2026

Jul 22, 2026

Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria - PR Newswire

Jul 22, 2026

Jul 21, 2026

Thomas Balzer Net Worth (2026) - GuruFocus

Jul 21, 2026

Jul 18, 2026

Lakewood-Amedex Biotherapeutics (LABT) Registration filing Summary - Quartr

Jul 18, 2026

Jul 17, 2026

Lakewood-Amedex Advances Nu-3 Gel Toward Phase 2a Trial - t.co

Jul 17, 2026

Jul 16, 2026

Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel - Sahm

Jul 16, 2026

Jul 15, 2026

Lakewood-Amedex Biotherapeutics (NASDAQ: LABT) maps Nu-3 iDFU trial path and IP - Stock Titan

Jul 15, 2026

Jul 15, 2026

Lakewood-Amedex reports preclinical safety data for Nu-3 gel By Investing.com - Investing.com South Africa

Jul 15, 2026